Eton Pharmaceuticals, which is developing liquid formulations of various approved drugs, announced terms for its IPO on Tuesday.
The Deer Park, IL-based company plans to raise $18 million by offering 3 million shares at a price of $6. At that price, Eton Pharmaceuticals would command a fully diluted market value of $110 million.
Eton Pharmaceuticals was founded in 2017 and plans to list on the Nasdaq under the symbol ETON. National Securities is the sole bookrunner on the deal.
